{"title":"NEURIM PHARMACEUTICALS (1991) LTD诉GENERICS (UK) LTD (No. 2)","authors":"","doi":"10.1093/rpc/rcad037","DOIUrl":null,"url":null,"abstract":"\n H1 Patents — European patents — Pharmaceuticals — Insomnia treatments — Melatonin — Validity — Concurrent proceedings before EPO — European Patent (UK) held valid by Patents Court — Patent later revoked by the EPO Technical Board of Appeal — Second action brought in relation to patent granted on divisional application — Preliminary issues — Issue estoppel — Winner’s appeals — Permission to appeal refused — Abuse of process — Competition law — Case management","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NEURIM PHARMACEUTICALS (1991) LTD v GENERICS (UK) LTD (No. 2)\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcad037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n H1 Patents — European patents — Pharmaceuticals — Insomnia treatments — Melatonin — Validity — Concurrent proceedings before EPO — European Patent (UK) held valid by Patents Court — Patent later revoked by the EPO Technical Board of Appeal — Second action brought in relation to patent granted on divisional application — Preliminary issues — Issue estoppel — Winner’s appeals — Permission to appeal refused — Abuse of process — Competition law — Case management\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcad037\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcad037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
NEURIM PHARMACEUTICALS (1991) LTD v GENERICS (UK) LTD (No. 2)
H1 Patents — European patents — Pharmaceuticals — Insomnia treatments — Melatonin — Validity — Concurrent proceedings before EPO — European Patent (UK) held valid by Patents Court — Patent later revoked by the EPO Technical Board of Appeal — Second action brought in relation to patent granted on divisional application — Preliminary issues — Issue estoppel — Winner’s appeals — Permission to appeal refused — Abuse of process — Competition law — Case management
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
